InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Lydon Nicholas, Director. Insider active across 1 companies, notably Blueprint Medicines Corp. Cumulatively, 4 reports have been logged. The latest transaction was filed on 21 June 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
02,600 shares0
Common Stock
SEC:0001415889-22-007132:0·
€199,44910,909 shares@ €18.283100.0% of flow
Common Stock
SEC:0001415889-22-005656:0·
02,250 shares0
Common Stock
SEC:0001179110-21-006414·
02,250 shares0
Common Stock
SEC:0001179110-21-006414:0·
4 of 4 declarations
About Lydon Nicholas
Nicholas Lydon is a Board Member at Blueprint Medicines Corp. He plays a key role in the governance of the company, contributing to strategic decision-making and overseeing activities.
